Histopathological and Molecular Characterization of Amlodipine-Induced Gingival Enlargement: Insights into Fibrotic Mechanisms
Open Access
- 24 December 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (1) , 45
Abstract
Background/Objectives: Amlodipine, a widely prescribed calcium channel blocker, has been associated with gingival enlargement, yet the mechanisms underlying this adverse effect remain unclear. The present study aimed to explore molecular and histopathological factors potentially contributing to gingival changes in patients receiving amlodipine therapy, with a particular focus on molecules implicated in extracellular matrix turnover and tissue remodeling. Methods: The study included three groups of participants: patients with amlodipine-induced gingival enlargement, patients with gingival enlargement of inflammatory origin, and amlodipine-treated patients without gingival overgrowth. Gingival tissue samples were analyzed using hematoxylin-eosin staining to assess inflammatory changes and general tissue architecture, and Picrosirius Red staining to visualize collagen fibers. Relative gene expression of alpha-smooth muscle actin (α-SMA), IL-13, MMP-1, and procollagen was determined by real-time PCR, while collagen content was quantified using ImageJ software. Results: Histopathological evaluation revealed a less pronounced inflammatory response in amlodipine-related gingival enlargement compared to those who did not use amlodipine. The highest expression of α-SMA was detected in patients who did not receive amlodipine, whereas IL-13 and procollagen expression were markedly elevated in the amlodipine-induced group compared to others. MMP-1 expression was significantly lower in amlodipine-treated patients relative to those who did not use amlodipine, suggesting impaired collagen degradation. These findings, together with our previous results indicating enhanced expression of profibrotic mediators, suggest that altered extracellular matrix metabolism is potentially dominant in this condition. Conclusions: Amlodipine-induced gingival enlargement appears to involve a multifactorial process characterized by a prominent fibrotic component, reduced matrix degradation, and secondary inflammation.Keywords
Funding Information
- the Faculty of Medical Sciences, University of Kragujevac, Serbia (01-773/1)
- The Ministry of Science, Technological Development and Innovation of the Republic of Serbia (451-03-137/2025-03/200111)
This publication has 31 references indexed in Scilit:
- One-step detection of procollagen type III N-terminal peptide as a fibrosis biomarker using fluorescent immunosensor (quenchbody)Analytica Chimica Acta, 2024
- Pathogenesis of periodontitis – A potential role for epithelial-mesenchymal transitionJapanese Dental Science Review, 2022
- Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseasesNature Reviews Rheumatology, 2019
- High Glucose Intake Exacerbates Autoimmunity through Reactive-Oxygen-Species-Mediated TGF-β Cytokine ActivationImmunity, 2019
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1Journal of Experimental Medicine, 2001
- Amlodipine Inhibits Expression of Matrix Metalloproteinase-1 and Its Inhibitor in Human Vascular Endothelial CellsJournal of Cardiovascular Pharmacology, 2000
- Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblastsJournal of Periodontal Research, 2000
- A clinical review of drug‐induced gingival overgrowthsAustralian Dental Journal, 1999
- The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patientsJournal of Clinical Periodontology, 1985